EVOFEM BIOSCIENCES, INC. Deferred Tax Assets, Capital Loss Carryforwards
EVOFEM BIOSCIENCES, INC. (EVFM) had Deferred Tax Assets, Capital Loss Carryforwards of $133.08 million as of 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-03-11
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $133.08M.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $131.57M.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $130.75M.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $126.06M.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2025-12-31 | $133.08M 10-K · filed 2026-03-11 |
| 2024-12-31 | $131.57M 10-K · filed 2026-03-11 |
| 2023-12-31 | $130.75M 10-K · filed 2025-03-24 |
| 2022-12-31 | $126.06M 10-K · filed 2024-03-27 |
| 2021-12-31 | $112.89M 10-K · filed 2023-04-27 |
| 2020-12-31 | $78.12M 10-K · filed 2022-03-10 |
| 2019-12-31 | $62.95M 10-K · filed 2021-03-04 |
| 2018-12-31 | $53.93M 10-K · filed 2020-03-12 |
| 2017-12-31 | $42.28M 10-K · filed 2019-03-01 |
| 2016-12-31 | $49.91M 8-K/A · filed 2018-04-06 |